IX BIOPHARMA LTD.
🇸🇬Singapore
- Country
- 🇸🇬Singapore
- Ownership
- Public
- Established
- 2008-01-01
- Employees
- 68
- Market Cap
- -
- Website
- http://www.ixbiopharma.com
Clinical Trials
8
Active:0
Completed:8
Trial Phases
2 Phases
Phase 2:4
Phase 3:1
Drug Approvals
2
HSA:2
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 2
4 (80.0%)Phase 3
1 (20.0%)Study of Wafermine™ for Post-bunionectomy or Abdominoplasty Pain
Phase 2
Completed
- Conditions
- AbdominoplastyAcute PainBunion
- Interventions
- Drug: PlacebosDrug: Wafermine™ 50 mgDrug: Wafermine™ 75 mgDrug: Wafermine™ 25 mg
- First Posted Date
- 2017-08-11
- Last Posted Date
- 2018-07-23
- Lead Sponsor
- iX Biopharma Ltd.
- Target Recruit Count
- 125
- Registration Number
- NCT03246971
- Locations
- 🇺🇸
Lotus Clinical Research, Pasadena, California, United States
Crossover Study to Evaluate the PK Effects of Two Different Wafer Administration Protocols.
- First Posted Date
- 2016-08-05
- Last Posted Date
- 2016-08-19
- Lead Sponsor
- iX Biopharma Ltd.
- Target Recruit Count
- 10
- Registration Number
- NCT02857361
- Locations
- 🇦🇺
Linear Clinical Research, Nedlands, Western Australia, Australia
A Pivotal Study of the Bioequivalence of Oral Viagra® and a Test Sublingual Sildenafil Wafer
Phase 3
Completed
- Conditions
- Erectile Dysfunction
- Interventions
- First Posted Date
- 2016-08-01
- Last Posted Date
- 2016-08-19
- Lead Sponsor
- iX Biopharma Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT02850718
- Locations
- 🇦🇺
Linear Clinical Research, Perth, Western Australia, Australia
A Study Of The Effectiveness Of Wafermine Alone And In Combination With Opioids In Subjects Undergoing Bunionectomy
- First Posted Date
- 2015-09-04
- Last Posted Date
- 2016-02-23
- Lead Sponsor
- iX Biopharma Ltd.
- Target Recruit Count
- 72
- Registration Number
- NCT02541396
- Locations
- 🇺🇸
Jean Brown Research, Salt Lake City, Utah, United States
Study Testing Ketamine Sublingual Wafer After Wisdom Tooth Extraction
- First Posted Date
- 2015-02-06
- Last Posted Date
- 2015-03-26
- Lead Sponsor
- iX Biopharma Ltd.
- Target Recruit Count
- 80
- Registration Number
- NCT02356965
- Locations
- 🇺🇸
Jean Brown Research, Salt Lake City, Utah, United States
- Prev
- 1
- 2
- Next
News
No news found